Epidermal naevus and naevus sebaceous

Meet the patient

A worried mother brings her 6-month-old daughter in for "a birthmark on her scalp". There is a smooth, yellow-orange, hairless plaque on the vertex — a naevus sebaceous, present since birth. She has read online that it "turns into cancer" and wants it cut out now. The examination is otherwise normal, the child is developing well, and there is no family history of skin disease.[1][10]

Two questions decide what you say to this mother, and they are the two that decide every epidermal-naevus case: is this an isolated lesion or part of a syndrome? (examine for seizures, development, limb and eye signs) and does it actually need to come out? (the modern answer for naevus sebaceous is usually no — watch and biopsy only on change). Hold those two questions and you will neither over-treat nor miss a Schimmelpenning child.[6][9]

The unifying concept — a cutaneous map of a mutant clone

Every epidermal naevus is a cutaneous map of a clone of cells carrying a postzygotic mutation, and the map it draws is Blaschko's lines. A mutation arises after fertilisation, producing a mosaic individual in whom some cells carry the change and some do not; the affected clone then migrates along the paths of embryonic ectodermal cell movement and appears on the skin as a linear, swirled, or segmental pattern.[6]

Because the mutation is acquired during embryogenesis and usually not in the germline, most cases are sporadic and not inherited. If the mutation affects cells that also contribute to the brain, skeleton, eye, or viscera, an epidermal naevus syndrome results — which is why extensive lesions, especially on the head and neck, demand a systemic screen.[6]

Blaschko's lines are not dermatomes, not Langer's lines, and not blood vessels. They reflect the direction of ectodermal cell migration during embryonic development — S-shaped whorls on the trunk, longitudinal on the limbs, whorled on the scalp. This pattern explains why epidermal naevi are linear or segmental but never dermatomal.[1]

Etymology for viva gold: naevus is from the Latin naevus, a birthmark; hamartoma from the Greek hamartia, "to miss the mark" — a disorganised but benign proliferation of native tissue, a developmental near-miss rather than a tumour. Sebaceous names the dominant gland, not the whole lesion, which is why "organoid" is the more honest umbrella.[6]

Two big families — keratinocytic versus organoid

Classify by the predominant tissue of origin first, because the family drives the differential, the syndrome risk, and the treatment. Keratinocytic epidermal naevi arise from keratinocytes; organoid epidermal naevi arise from adnexal structures — sebaceous glands, hair follicles, or smooth muscle.[1]

[1]

The cluster rule for keratinocytic variants — V-I-E-N: Verrucous (the classic warty plaque), Inflammatory (ILVEN, the itchy psoriasiform one), Epidermolytic (EEN, the one that carries the gonadal-mosaicism risk), Naevus comedonicus (the cluster of keratin-plugged follicles). One image, four variants, no list to forget.[1]

Why the lesion follows Blaschko — the molecular map

The molecular basis of epidermal naevi is a postzygotic somatic activating mutation in genes that regulate epidermal and adnexal growth, and the gene predicts the phenotype. The 2012 Nature Genetics paper established that postzygotic activating mutations in HRAS or KRAS in the developing ectoderm cause both naevus sebaceous and Schimmelpenning syndrome — mosaic RASopathies.[9]

The key genes and their phenotypes are worth memorising because they recur in the viva. FGFR3 and PIK3CA drive keratinocytic verrucous naevi through epidermal proliferation and the PI3K-AKT-mTOR pathway — the same pathways implicated in Proteus syndrome and megalencephaly-capillary malformation. HRAS and KRAS drive naevus sebaceous and Schimmelpenning. KRT1 and KRT10 produce epidermolytic epidermal naevus — the same genes that cause bullous congenital ichthyosiform erythroderma when the mutation is germline.[6]

Activating HRAS or KRAS drive the RAS-MAPK and PI3K-AKT pathways, promoting proliferation, survival, and migration. Because the mutation sits in ectodermal cells that also give rise to parts of the brain, eye, and skeleton, the same mutant clone can produce both the cutaneous naevus and the extracutaneous malformations of Schimmelpenning syndrome — severity tracks the timing and tissue distribution of the mutation.[9]

Naevus sebaceous — the lifecycle and the BCC myth

Naevus sebaceous (Jadassohn naevus) is the prototypical organoid naevus, and it has a lifecycle that examiners love: flat and hairless at birth, thickening and verrucous at puberty, and carrying a low — not high — risk of secondary tumour. At birth it is a well-circumscribed, yellow-orange, velvety, hairless plaque, most often on the scalp or face; under androgen stimulation at puberty the sebaceous and apocrine components enlarge, and it becomes thicker, greasier, and more verrucous.[6]

The classic trap — and the one examiners now mark down: the old teaching that naevus sebaceous carries a 10 to 30 percent risk of malignant transformation is wrong. An 18-year institutional review found that the risk of malignancy is small, and many lesions previously labelled basal cell carcinoma were actually benign trichoblastomas. Modern series put the overall secondary-neoplasm rate around 12.8 percent, with malignant transformation around 2.4 percent and BCC-specific risk roughly 0 to 1.7 percent — which is why routine prophylactic excision is no longer the standard.[10]

Current recommendations: observation for most asymptomatic lesions with regular photography and examination; biopsy of any new nodule, papule, ulceration, or bleeding to exclude BCC, trichoblastoma, or syringocystadenoma papilliferum; and excision only if the lesion is symptomatic, cosmetically unacceptable, or shows suspicious change.[1][10]

ILVEN — the itchy one that will not respond to steroids

Inflammatory linear verrucous epidermal naevus (ILVEN) is intensely pruritic, psoriasiform, follows Blaschko's lines, and is famously refractory to topical corticosteroids — and that refractoriness is itself a diagnostic clue. It appears in early childhood, often before age 5, is more common in girls (female-to-male roughly 4 to 1), and favours the lower limbs, buttocks, and trunk.[7]

The classic trap: ILVEN is most often mistaken for linear psoriasis. The distinction is clinical — ILVEN is intensely pruritic, refractory to topical steroids, and often more erythematous and scaly along its entire length. A therapeutic trial of potent topical corticosteroid or calcipotriol helps, because psoriasis usually improves whereas ILVEN does not; the histology can be identical to psoriasis, so the clinical history is decisive.[7]

Becker naevus and epidermolytic EEN — two variants with counselling hooks

Becker naevus presents in adolescence, almost always in males, as a unilateral brown hyperpigmented patch that gradually enlarges, darkens, and develops dark terminal hairs on the shoulder, upper chest, or upper back. It is androgen-dependent — androgen receptors are upregulated in lesional skin — and it may associate with ipsilateral breast hypoplasia, scoliosis, or limb shortening in Becker naevus syndrome.[1][2]

Epidermolytic epidermal naevus (EEN) is the variant with the counselling hook examiners test. Mutations in keratin 1 or keratin 10 produce a verrucous linear plaque with epidermolytic hyperkeratosis on histology — the same genes that cause bullous congenital ichthyosiform erythroderma when the mutation is present in the germline. If the patient has gonadal mosaicism, offspring can inherit the full-blown genodermatosis — so offer genetic counselling before pregnancy.[1]

Epidermal naevus syndrome (Schimmelpenning) — screen the systems

Schimmelpenning syndrome is a neurocutaneous mosaic disorder in which a naevus sebaceous — usually on the face or scalp — sits with ipsilateral extracutaneous anomalies, and missing it is the case-losing error. The underlying basis is postzygotic activating mutations in HRAS or KRAS, present in both the naevus and affected internal organs.[9]

The extracutaneous associations to screen for: neurological (seizures, intellectual disability, hemimegalencephaly, hydrocephalus); ocular (coloboma, choristoma, strabismus, visual impairment); skeletal (limb length discrepancy, scoliosis); and the endocrine jewel — hypophosphataemic rickets, driven by FGF23 produced by the naevus tissue, causing renal phosphate wasting, bowing, and short stature.[3][4]

Any infant with a large naevus sebaceous on the head or neck — or any child with a large epidermal naevus and neurological or skeletal signs — should be evaluated for an epidermal naevus syndrome with a full systemic examination and targeted imaging.[1][6]

The bedside round — map, morphology, systems

The bedside assessment of a suspected epidermal naevus has three goals: confirm the diagnosis clinically, identify the subtype, and look for a syndrome. First, map the distribution — linear, S-shaped, or whorled patterns following Blaschko's lines are characteristic, and a dermatomal pattern points elsewhere.[1]

Second, examine the morphology — a yellow-orange hairless plaque on the scalp or face is naevus sebaceous; a pruritic, erythematous, scaly linear plaque is ILVEN; a brown velvety warty linear plaque is a verrucous epidermal naevus; a hyperpigmented, hypertrichotic patch on the shoulder is Becker naevus.[1]

Third, search for systemic associations — head circumference and developmental milestones, seizures and hemiparesis, limb length discrepancy and scoliosis, visual acuity and coloboma. Any large head-and-neck naevus sebaceous in an infant warrants a multisystem work-up.[3]

Investigations — clinical first, biopsy the doubt

Most epidermal naevi are diagnosed clinically; investigations are reserved for atypical presentations, suspected malignancy, and suspected systemic associations. Skin biopsy is the definitive test when the diagnosis is uncertain — a shave or punch from lesional skin is usually adequate.[1]

The histological patterns are worth knowing: verrucous epidermal naevus shows acanthosis, papillomatosis, and hyperkeratosis; ILVEN shows psoriasiform hyperplasia with parakeratosis (identical to psoriasis — clinical context decides); epidermolytic EEN shows vacuolated granular keratinocytes with clumped tonofilaments; naevus sebaceous shows mature sebaceous lobules draining directly onto the surface with immature hair follicles and apocrine glands; Becker naevus shows acanthosis with increased dermal smooth muscle.[1]

Imaging and systemic work-up are indicated when a syndrome is suspected: MRI brain for seizures, developmental delay, or hemiparesis; skeletal survey for rickets, scoliosis, or limb discrepancy; and serum phosphate, calcium, alkaline phosphatase, parathyroid hormone, and FGF23 if hypophosphataemic rickets is in the differential. Baseline photography with a ruler is an investigation in its own right — it is the cheapest surveillance tool and the one that catches a new nodule earliest.[1][3]

Management — conservative is the modern default

For most small, asymptomatic epidermal naevi, observation is the correct and evidence-based choice — the lesions are benign, stable after childhood, and do not require treatment unless they cause symptoms or significant cosmetic concern. The management shift in naevus sebaceous from routine prophylactic excision to conservative surveillance is the single most testable change in this topic.[1][10]

For symptomatic or cosmetically bothersome verrucous epidermal naevus and ILVEN, medical options include topical calcipotriol 0.005 percent, topical corticosteroids (often refractory in ILVEN — itself a diagnostic clue), and topical retinoids. Procedural options include full-thickness excision for small to medium lesions, and laser ablation with CO2 or erbium-YAG — which can flatten and lighten lesions but is not curative, with recurrence common and multiple sessions usually required.[5][8]

[1]

Becker naevus is managed conservatively; laser hair removal or electrolysis addresses the hypertrichosis, and pigment-specific lasers can lighten the hyperpigmentation, though results are variable. Excision is rarely needed, and associated breast hypoplasia or skeletal asymmetry may require reconstructive or orthopaedic referral.[1][2]

Specific syndromes — CHILD and the overgrowth overlaps

CHILD syndrome is the most striking of the Blaschkoid syndromes and a favourite examination stem. The name is the acronym: Congenital Hemidysplasia with Ichthyosiform naevus and Limb Defects — a unilateral ichthyosiform naevus following Blaschko's lines, ipsilateral limb undergrowth, and internal organ involvement, caused by mutations in NSDHL on the cholesterol-biosynthesis pathway. It is usually lethal in males; most affected patients are female because of X-inactivation mosaicism.[12]

Proteus syndrome, caused by postzygotic activating AKT1 mutations, overlaps with epidermal naevus syndrome through asymmetric, disproportionate overgrowth of skin, bone, muscle, and fat, with cerebriform connective tissue naevi — extensive epidermal naevi with overgrowth should prompt consideration of the PIK3CA-related overgrowth spectrum.[1][11]

Prognosis, disposition, and special populations

Most isolated epidermal naevi have an excellent prognosis — they are benign, stable after childhood, and do not affect life expectancy. Cosmetic concern is the commonest indication for treatment; recurrence after complete excision is uncommon, while recurrence after laser or destructive therapy is common.[1]

Long-term follow-up matters most for naevus sebaceous, where malignancy can develop decades after puberty, so educate the patient to self-examine and report any new nodule, bleeding, ulceration, or rapid change. For Schimmelpenning syndrome, prognosis is determined by the severity of neurological, skeletal, and ocular disease and requires multidisciplinary follow-up into adulthood.[6][9]

In skin of colour, post-inflammatory hyperpigmentation and hypertrophic scarring are more common after excision or laser, so conservative management and meticulous wound care are especially important — counsel realistic expectations about dyspigmentation and scarring before any procedure.[1]

The mantra, and the mnemonic

[1]

The mantra: Blaschko means mosaic; sebaceous means watch, not cut; ILVEN means itchy and steroid-refractory; and a head naevus plus seizures means Schimmelpenning.[1][9]

[1]

Ward-round test

Stem 1 — A mother wants her 6-month-old daughter's congenital yellow-orange hairless scalp plaque excised because she read it "turns into cancer". The child is developing normally and the lesion is unchanged. What do you counsel, and what is the plan?[10]

Answer

This is naevus sebaceous. The old teaching of a high (10 to 30 percent) malignant transformation rate has been revised — an 18-year review showed the risk is small, and many lesions previously labelled BCC were benign trichoblastomas, with BCC-specific risk roughly 0 to 1.7 percent. Modern management is conservative surveillance: reassure the mother, take baseline photography, examine periodically, and biopsy any new nodule, ulceration, or bleeding. Routine prophylactic excision is no longer the standard.[1][10]

Stem 2 — A 4-year-old girl has a pruritic, erythematous, scaly linear plaque on her leg following Blaschko's lines since age 2. Potent topical corticosteroids have not helped. What is the likely diagnosis, and what distinguishes it from its closest mimic?[7]

Answer

This is inflammatory linear verrucous epidermal naevus (ILVEN). Its closest mimic is linear psoriasis, and the distinction is clinical: ILVEN is intensely pruritic, more common in girls (about 4 to 1), and famously refractory to topical corticosteroids — and that refractoriness is itself the diagnostic clue, because psoriasis usually responds. Histology can be identical to psoriasis, so the clinical history and distribution are decisive.[7]

Stem 3 — A 3-month-old boy has a large naevus sebaceous on his forehead and has just had a seizure. What syndrome is suspected, what systemic screen is mandatory, and what endocrine complication must you check for?[9]

Answer

This is Schimmelpenning (epidermal naevus) syndrome — a naevus sebaceous on the head or neck with ipsilateral extracutaneous anomalies, caused by somatic HRAS or KRAS mutations. Screen the neurological system (MRI brain for hemimegalencephaly, developmental delay), the ocular system (coloboma, choristoma), and the skeletal system (limb length discrepancy, scoliosis). The endocrine complication to check for is FGF23-mediated hypophosphataemic rickets — serum phosphate, calcium, alkaline phosphatase, parathyroid hormone, and FGF23.[3][9]

Stem 4 — A woman with an epidermolytic epidermal naevus on her flank asks whether her future children could inherit a skin disease. What is the genetic risk, and what do you advise?[1]

Answer

Epidermolytic epidermal naevus is caused by mutations in keratin 1 or keratin 10 — the same genes that cause bullous congenital ichthyosiform erythroderma when the mutation is present in the germline. If the patient has gonadal mosaicism, offspring can inherit the full-blown genodermatosis. Offer genetic counselling before pregnancy, with consideration of genetic testing of affected skin and, where available, prenatal counselling to inform reproductive decisions.[1][6]

References

1. [1]Arjona-Aguilera C, Collantes-Rodríguez C, Villegas-Romero I, et al. Rounded and velvety epidermal naevus: Dermoscopic findings and literature review Australas J Dermatol, 2018.PMID 28736849
2. [2]Schäfer K, Bauer B, Donhauser J, et al. Becker Naevus Syndrome of the Lower Body: One Case and Review of the Literature Acta Derm Venereol, 2017.PMID 27882383
3. [3]Olivares JL, Ramos FJ, Carapeto FJ, et al. Epidermal naevus syndrome and hypophosphataemic rickets: description of a patient with central nervous system anomalies and review of the literature Eur J Pediatr, 1999.PMID 10048604
4. [4]Zakrzewski JL, Luecke T, Bentele KH, et al. Epidermal naevus and segmental hypermelanosis associated with an intraspinal mass: overlap between different mosaic neuroectodermal syndromes Eur J Pediatr, 2001.PMID 11686504
5. [5]Khan W, Ibrahim A, Alvaro A, et al. Laser Treatment of Verrucous Epidermal Naevi: A Systematic Review J Cutan Med Surg, 2022.PMID 35603930
6. [6]Waldman AR, Garzon MC, Morel KD Epidermal Nevi: What Is New Dermatol Clin, 2022.PMID 34799036
7. [7]Atzmony L, Ugwu N, Hamilton C, et al. Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders Pediatr Dermatol, 2022.PMID 35853659
8. [8]Alkhalifah A, Fransen F, Le Duff F, et al. Laser treatment of epidermal nevi: A multicenter retrospective study with long-term follow-up J Am Acad Dermatol, 2020.PMID 31202870
9. [9]Groesser L, Herschberger E, Ruetten A, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome Nat Genet, 2012.PMID 22683711
10. [10]Rosen H, Schmidt B, Lam HP, et al. Management of nevus sebaceous and the risk of Basal cell carcinoma: an 18-year review Pediatr Dermatol, 2009.PMID 19686305
11. [11]Farschtschi S, Mautner VF, Hollants S, et al. Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation BMC Med Genet, 2015.PMID 25928347
12. [12]Ramphul K, Kota V, Sathe NC, et al. CHILD Syndrome 2026.PMID 29939590